Deni Hardiansyah, Dr. sc. hum

BIOGRAPHICAL SKETCH:

Dr. sc. hum. Deni Hardiansyah
Associate Professor,
Medical Physics and Biophysics Research Group,
Physics Department, Faculty of Mathematics and Natural Sciences (FMIPA),
Universitas Indonesia, Indonesia.

Building F (Physics Department), FMIPA UI, University of Indonesia, Depok, 16424
Email:
(University): denihardiansyah@ui.ac.id
(Faculty): denihardiansyah@sci.ui.ac.id

.
Qualifications
Education

Dr. Hardiansyah is a lecturer at the Physics Department FMIPA, Universitas Indonesia. Dr. Hardiansyah earned a doctoral degree at Heidelberg University, Germany, with a focus on the implementation of physiologically based pharmacokinetic (PBPK) model to improve individual dosimetry in Molecular Radiotherapy. In addition to the Molecular radiotherapy, he also published several papers in the field of molecular/functional imaging. After his PhD, he worked as a postdoc and staff at the College of Pharmacy, University of Kentucky, USA, in the field of pharmaceutical sciences. In general, he has carried out research in various aspects of nuclear medicine dosimetry, imaging and modeling of drug’s PKPD.

2013 – 2016     Dr. sc. hum. (2.5 years), Heidelberg University, Germany

2011 – 2013     MSi. (1.5 years), Institut Teknologi Bandung, Indonesia
2006 – 2010     SPd. (3 years and 10 months), Universitas Pendidikan Indonesia, Indonesia

.
About
Research Interest
Book Chapter

Medical Physics
Nuclear Medicine
Molecular Radiotherapy/ Radiopharmaceutical Therapy
Non-Linear Mixed-Effects (NLME) Modeling
Peptide-Receptor Radionuclide Therapy (PRRT)
Prostate-Specific Membrane Antigen (PSMA) Therapy
Molecular/Functional Imaging
Pharmaceutical Sciences
Physiologically-Based Pharmacokinetic (PBPK) Modeling
Quantitative Systems Pharmacology (QSP) Modeling

Hardiansyah D, Ng CM. Quantitative Pharmacology and Individualized Therapy Strategies in Development of Therapeutic Proteins for Immune-Mediated Inflammatory Diseases. Chapter: Quantitative Pharmacology Approach to Select Optimal Dose and Study the Important Factors in Determining Disposition of Therapeutic Monoclonal Antibody in Pediatric Subjects – Some Considerations. March 2019. Wiley, ISBN: 978-1-119-28919-7.

Publications
.
Students/Research Assistant

We usually reply with 24 hours except for weekends. All emails are kept confidential and we do not spam in any ways.

Thank you for contacting us :)

Enter a Name

Enter a valid Email

Message cannot be empty

X